Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Arch Surg. 2011 Jun;146(6):724–732. doi: 10.1001/archsurg.2011.129

Figure 5.

Figure 5

Kaplan Meier plot of total survival (upper panel) and disease-free survival (lower panel) based on the clinical production of a hormone (gastrin and glucagon); that is, defined as functional vs non-functional pancreatic endocrine tumor (NF-PET). Functional PET had a significantly better total survival than NF-PET (p<0.001, upper panel), but there was no difference in disease-free survival (lower panel).